ArticleFrontiers in neurology
Automated detection of hyperdense artery sign on non-contrast CT for rapid identification of large vessel occlusion: a multicenter validation study.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Computed tomography angiography (CTA) is the gold standard for detecting large vessel occlusion, but its acquisition and reconstruction delay time-critical workflow. The hyperdense artery sign (HAS) on non-contrast CT (NCCT) offers an immediate, albeit subtle, marker. We developed a fully automated deep-learning model for HAS detection and evaluated its utility as an adjunctive pre-CTA alert to support earlier workflow readiness while confirmatory vascular imaging is pending. Furthermore, we assessed the radiological validity of the model's detections to ensure they correspond to genuine thrombi rather than artifacts. Methods: We trained a 3-step deep-learning pipeline (midline correction, ischemic core segmentation, HAS segmentation) on 690 NCCT scans. Clinical validation was performed in two complementary cohorts: Part 1A, a multicenter CSC triage cohort ( Results: In Part 1A, the model achieved a sensitivity of 76.2% (80/105), specificity of 87.0% (47/54), accuracy of 79.9% (127/159), and PPV of 92.0% (80/87), indicating high reliability of positive alerts in a CSC triage setting. In Part 1B, the model achieved a sensitivity of 74.3% (26/35), specificity of 82.7% (158/191), PPV of 44.1% (26/59), NPV of 94.6% (158/167), and accuracy of 81.4% (184/226), reflecting preserved discrimination in a lower-prevalence, broader real-world population. In the reader study, model assistance significantly improved HAS-detection performance, increasing JAFROC Figure of Merit from 0.71 to 0.77 ( Conclusion: The proposed model enables rapid HAS detection on NCCT and demonstrated complementary performance across two validation settings: high reliability of positive alerts in a workflow-enriched CSC triage cohort and preserved sensitivity/specificity in a broader consecutive cohort. These findings support its role as an adjunctive pre-CTA alert for earlier workflow readiness in high-probability settings, not as a stand-alone rule-out tool. The observer study further supports the radiological validity of the AI-highlighted regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.